Randomized Trial of Anetumab Ravtansine and Pembrolizumab Compared to Pembrolizumab for Mesothelioma
Aaron S. Mansfield,Jun Vivien Yin,Penelope Bradbury,David J. Kwiatkowski,Shiven Patel,Lyudmila A. Bazhenova,Patrick Forde,Yanyan Lou, Paul Dizona,Liza C. Villaruz,Susanne M. Arnold,Maya Khalil,Hedy L. Kindler,Marianna Koczywas,Jose Pacheco,Christian Rolfo,Bing Xia, Elizabeth Mikula, Li Chen, Kashish Patel, Katherine E. R. Smith,Liang Cao,Geoffrey Shapiro,Brian A. Costello, Alex Adjei,Elad Sharon, Jeffrey A. Moscow, William Zamboni, Raffit Hassan LUNG CANCER（2024）
关键词
Mesothelioma,Mesothelin,Antibody-drug conjugate,PD-1,Immune checkpoint inhibitor
AI 理解论文
溯源树
样例
